Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Lunac Therapeutics Logo
Lunac Therapeutics Growth Score
24
CB Rank
109980
Heat Score
12
Lunac Therapeutics is a UK-based drug discovery company.
Founded
obfuscation
PrivateVenture - Series Unknown Leeds, Leeds, United Kingdom1-10 www.lunactherapeutics.com
Biotechnology
Therapeutics
Overview

Lunac Therapeutics
Total Funding
obfuscation
Growth Score
24
Heat Score
12

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score24
-1 pts
in past quarter
Heat Score 12
-17 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Lunac Therapeutics

CB Rank
109980
Lunac Therapeutics is a UK-based drug discovery company.
Founded
obfuscation
PrivateVenture - Series Unknown Leeds, Leeds, United Kingdom1-10 www.lunactherapeutics.com
Biotechnology
Therapeutics

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Key People

Details

Legal Name LUNAC Therapeutics Limited
Operating Status Active
Company Type For Profit
Founders  Helen Philippou, Richard Foster
About the Company
Epidarex Capital invests in early-stage, high growth life science and health technology Epidarex Capital is a transatlantic venture fund that invests in early-stage, high growth life science and health technology companies in under-ventured markets.
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Activated Factor XII (FXIIa) Inhibitor Anticoagulants
Oral and intravenous anticoagulant drugs targeting activated Factor XII to prevent thrombosis without increasing bleeding risk.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Lunac Therapeutics Logo
Venture Round - Lunac Therapeutics
3
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Lunac Therapeutics Logo
Venture Round - Lunac Therapeutics
3
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Lunac Therapeutics Logo
Venture Round - Lunac Therapeutics
3
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Lunac Therapeutics Logo
Venture Round - Lunac Therapeutics
3
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Lunac Therapeutics Logo
Venture Round - Lunac Therapeutics
3
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Lunac Therapeutics Logo
Venture Round - Lunac Therapeutics
3
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Lunac Therapeutics Logo
Venture Round - Lunac Therapeutics
3
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Lunac Therapeutics Logo
Venture Round - Lunac Therapeutics
3
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Lunac Therapeutics Logo
Venture Round - Lunac Therapeutics
3
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Lunac Therapeutics Logo
Venture Round - Lunac Therapeutics
3
obfuscation
— Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Epidarex Capital Logo
Epidarex Capital
—
Venture Round - Lunac Therapeutics Logo
Venture Round - Lunac Therapeutics
—
Epidarex Capital Logo
Epidarex Capital
—
Venture Round - Lunac Therapeutics Logo
Venture Round - Lunac Therapeutics
—
Epidarex Capital Logo
Epidarex Capital
—
Venture Round - Lunac Therapeutics Logo
Venture Round - Lunac Therapeutics
—
Epidarex Capital Logo
Epidarex Capital
—
Venture Round - Lunac Therapeutics Logo
Venture Round - Lunac Therapeutics
—
Epidarex Capital Logo
Epidarex Capital
—
Venture Round - Lunac Therapeutics Logo
Venture Round - Lunac Therapeutics
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Board Members and Advisors 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Dec 22, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 26, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 11, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$215.1KThis year, Lunac Therapeutics is projected to spend $215.1K on IT, according to Aberdeen.

Active Website Tech Count

3Lunac Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Twitch.

Total IP

3Lunac Therapeutics has 1 registered patent in the 'Organic Chemistry' category, according to IPqwery. Additionally, Lunac Therapeutics has registered 2 trademarks with the most popular class being 'Treatment of materials', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Lunac Therapeutics's headquarters? Lunac Therapeutics is located in Leeds, Leeds, United Kingdom.Who invested in Lunac Therapeutics? Lunac Therapeutics has 5 investors including Epidarex Capital and  Northern Powerhouse Investment Fund.When was the last funding round for Lunac Therapeutics? Lunac Therapeutics closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Lunac Therapeutics's competitors? Alternatives and possible competitors to Lunac Therapeutics may include Verve Therapeutics, Bristol-Myers Squibb, and  argenx.How much funding has Lunac Therapeutics raised to date? Lunac Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(250d0b0 1)
|